- Research works
- 61 ▼ 8% vs 2013–17
- Citations
- 707 11.6 per fractional work
- Top-10% rate
- 11.8% record average 16.5%
- Open access
- 30% world 28%
Not ranked overall: Erytech Pharma (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.2×. Every wedge is a field page.
Who are the top researchers at Erytech Pharma (France)?
Ranked on the composite score, Iman El‐Hariry lead among researchers whose main affiliation is Erytech Pharma (France).
- 1 Iman El‐Hariry France · #1,610,946 worldwide 12 citations · 15 works
Which keywords describe research at Erytech Pharma (France)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Tumor Regression, Tumor Microenvironment, Bacterial Therapy, Tumor Targeting, Prognostic Factors and Acute Lymphoblastic Leukemia.
- Circular Economy
- Lysosomal Storage Disorders
- Surgical Complications
- Gemcitabine
- Warburg Effect
- Pancreatic Cancer
- NK Cell Recognition
- HIF-1
- Dendritic Cells
- Chemotherapy
- Piezo1
- Cancer
- Microbial Communities
- Apoptosis
- Metabolic Health
- Oxidative Stress
- Acute Lymphoblastic Leukemia
- Tumor Targeting
- Tumor Microenvironment
- Gene Therapy
- Immunotherapy
- Tumor Regression
- Bacterial Therapy
- Prognostic Factors
- Childhood Cancer
- Inflammatory Diseases
- Erythropoiesis
- Gut Microbiota
- Parathyroid Hormone
- Cancer Immunotherapy
- Piezo2
- Innate Immunity
- Immunity
- Hypoparathyroidism
- Natural Killer Cells
- Thyroid Surgery
- Enzyme Regulation
- Parkinson's Disease
- Enzyme Replacement Therapy
- Metabolic Disorders
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy6▲ 16×6 topics
- Gene Therapy6▲ 35×4 topics
- Tumor Regression4▲ 84×2 topics
- Tumor Microenvironment4▲ 19×5 topics
- Bacterial Therapy4▲ 141×1 topic
- Tumor Targeting4▲ 47×1 topic
- Prognostic Factors4▲ 13×3 topics
- Acute Lymphoblastic Leukemia3▲ 149×1 topic
- Childhood Cancer3▲ 149×1 topic
- Oxidative Stress3▲ 3.0×12 topics
- Inflammatory Diseases3▲ 43×2 topics
- Metabolic Health3▲ 40×3 topics
- Erythropoiesis3▲ 55×2 topics
- Apoptosis3▲ 12×5 topics
- Gut Microbiota3▲ 13×1 topic
- Microbial Communities3▲ 13×1 topic
- Parathyroid Hormone3▲ 43×2 topics
- Cancer2▲ 3.0×4 topics
- Cancer Immunotherapy2▲ 29×2 topics
- Piezo12▲ 83×1 topic
- Piezo22▲ 83×1 topic
- Chemotherapy2▲ 4.4×5 topics
- Innate Immunity2▲ 8.7×2 topics
- Dendritic Cells2▲ 26×1 topic
- Immunity2▲ 8.8×1 topic
- HIF-12▲ 40×1 topic
- Hypoparathyroidism2▲ 130×1 topic
- NK Cell Recognition2▲ 27×1 topic
- Natural Killer Cells2▲ 27×1 topic
- Pancreatic Cancer2▲ 23×2 topics
- Thyroid Surgery2▲ 130×1 topic
- Warburg Effect2▲ 40×1 topic
- Enzyme Regulation1▲ 47×2 topics
- Gemcitabine1▲ 36×1 topic
- Parkinson's Disease1▲ 10.0×2 topics
- Surgical Complications1▲ 31×1 topic
- Enzyme Replacement Therapy1▲ 81×1 topic
- Lysosomal Storage Disorders1▲ 112×1 topic
- Metabolic Disorders1▲ 12×3 topics
- Circular Economy1▲ 9.5×2 topics
Which research topics does Erytech Pharma (France) publish most on?
By volume in 2022–2025: Gut microbiota and health, Cancer Research and Treatments, Thyroid and Parathyroid Surgery and Pancreatic and Hepatic Oncology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gut microbiota and health Molecular Biology 2 works
- 2 Cancer Research and Treatments Biotechnology 1 works
- 3 Thyroid and Parathyroid Surgery Surgery 1 works
- 4 Pancreatic and Hepatic Oncology Research Oncology 1 works
- 5 3D Printing in Biomedical Research Biomedical Engineering 1 works
- 6 Parathyroid Disorders and Treatments Nephrology 1 works
- 7 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works
- 8 Ion Transport and Channel Regulation Molecular Biology 0 works
- 9 Biochemical Acid Research Studies Biochemistry 0 works
- 10 Immunotherapy and Immune Responses Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Erytech Pharma (France)'s research output changed?
Output in 2018–2022 was 8% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lyon
- Laboratoire de Chimie
- École Normale Supérieure de Lyon
- Institut National des Sciences Appliquées de Lyon
- Hôpital Edouard Herriot
- Hospices Civils de Lyon
- Université Lumière Lyon 2
- Maison des Sciences sociales et des Humanités - Lyon St-Étienne
- Université Jean Moulin Lyon III
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.